CRDMO Services That Unlock Your Molecule’s True Potential

Discover the data-driven solutions you need to help bring your vision to life and accelerate your path to patients in need.
About us
a first-in-human clinical study a drug product manufacturing partner an integrated drug program pediatric formulation development
A trusted partner to help you stay in control, on course, and always one step ahead

 

Quotient Sciences’ truly integrated approach to drug development gives you the strategic edge to transform innovative ideas into successful solutions—taking your lead molecule from candidate selection, to first-in-human clinical testing, all the way through to commercial supply. 

Explore how we can help you optimize every step of the process, navigate critical milestones and efficiently advance your therapy on its journey to approval:     

Drug Product Development & Manufacturing
Experienced formulation development, clinical manufacturing, and sustained commercial production of your product.
Explore Service
Early Clinical Development
Integrated first-in-human and clinical pharmacology programs that help you make critical decisions earlier.
Discover More
Translational Pharmaceutics® Integrated Drug Development
Our unique approach to drug development, integrating clinical activities with real-time cGMP drug product manufacturing.
Discover More
How Can We Help?
Science-led solutions to match your toughest drug development challenges.
Discover More

Quotient Sciences Extends Commercial Manufacturing Partnership for Ultra-Rare Disease Treatment

Read News
Explore CRDMO Services

Integrated CRDMO services that bring therapies to life.

Quotient Sciences streamlines drug development by providing integrated CRDMO services spanning early clinical development—to reach key milestones such as first-in-human clinical trials—through to trusted, ongoing commercial drug manufacturing.

Explore Services
Start a Conversation
When time matters most, so does the right CRDMO partner. Let’s move your drug program forward.
Contact Us Ask the Experts